Skip to content

Clinical trials

Phase 2/3 Heart Failure trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2/3 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20053
20062
20072
20081
20091
20111
20143
20153
20161
20181
20201
20213
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated4
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation5
Columbia University2
VA Office of Research and Development2
Virginia Commonwealth University2
Abbott RDx Cardiometabolic1
Advanz Pharma1
AstraZeneca1
Bioheart, Inc.1
Biotronik, Inc.1
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure28
Heart Diseases2
Acute Coronary Syndrome1
Acute Kidney Injury1
Angina Pectoris1
Cardiomyopathies1
Cardiomyopathy, Hypertrophic1
Cardiomyopathy, Hypertrophic, Familial1
Coronary Artery Disease1
Dyspnea1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.